From pharmaceuticals to providers and patients, interest in theranostics is making it one of the fastest growing fields in oncology. In fact, it may usher in a whole new era of more personalized, predictive, and precise cancer treatment.
As momentum for theranostics builds, what will drive its adoption? In this paper, you’ll learn how innovations in imaging, clinical care, and research will mold the future of this treatment.
